Chad Skelton, Canwest News Service
Published: Monday, October 27, 2008
Researchers at the University of B.C. have discovered that a drug commonly used to treat epilepsy and bipolar disorder significantly reduces brain plaque in mice with Alzheimer's disease.
The discovery, if replicated in humans, could lead to major new treatments for the debilitating brain-wasting disease. "If this works . . . it's going to benefit every patient with Alzheimer's disease," said UBC psychiatry professor Weihong Song, who led the study.
Song and his colleagues took mice genetically modified to exhibit Alzheimer's-like symptoms and then treated them with valproic acid (VPA), a compound usually used as a mood stabilizer or anti-convulsant
They found the drug.....read the whole story